Is a complete ZJYL research report available?

No complete published report is available for Jin Medical International Ltd. (ZJYL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · USD

$2.06

-0.22 (-9.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ZJYL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	16.1M
Revenue (ttm)	20.7M
Net income (ttm)	1.2M
EPS (ttm)	$0.15
Shares out	7.8M
P/E (trailing)	13.5x
Volume	10,731
Beta	7.34

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20.7M
Net income (ttm): 1.2M
EPS (ttm): $0.15
P/E (trailing): 13.5x
Market cap: 16.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ZJYL indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001837821
Company name	Jin Medical International Ltd.
Country	China
Country code	US
Cusip	G5140V120
Employees	273
Employees Change	4%
Employees Change Percent	1.49
Enterprise value	$5.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
Industry PE	64.87
Industry PE Fwd	20.65
IPO Date	2023-03-28
Isin	KYG5140V1207
Last refreshed	2026-07-27
Market cap	$16.1M
Market cap category	Nano-Cap
Price	$2.06
Price currency	USD
Rev Per Employee	75,777.56x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	3842
Symbol	ZJYL
Website	https://www.zhjmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.39%
EV Earnings	4.54x
EV/EBIT	8.89x
EV/EBITDA	6.35x
EV/Sales	0.26x
FCF yield	-23.11%
P/B ratio	0.54x
P/E ratio	13.54x
P/S ratio	0.78x
PE Ratio3 Y	134.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.94%
EBITDA Margin	4.12%
Gross margin	30.18%
Gross Profit	$6.2M
Gross Profit Growth	-35.04%
Gross Profit Growth Q	11.33%
Gross Profit Growth3 Y	-0.61%
Gross Profit Growth5 Y	2.57%
Net Income	$1.2M
Net Income Growth	-67.59%
Net Income Growth Q	-31.97%
Net Income Growth Years	0%
Net Income Growth3 Y	-23.93%
Net Income Growth5 Y	-11.59%
Pretax Margin	7.71%
Profit Margin	5.76%
Profit Per Employee	$4,364
Profitable Years	5
ROA	0.77
Roa5y	5.42
ROCE	2.06
ROE	4.75
Roe5y	14.43
ROIC	2.79
Roic5y	20.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-85.3%
Cagr3y	-42.34%
EPS Growth	-67.61
EPS Growth Q	-31.97
EPS Growth Years	0
EPS Growth3 Y	-27.6
EPS Growth5 Y	6.65
OCF Growth3 Y	22.47%
OCF Growth5 Y	3.01%
Revenue Growth	-11.98x
Revenue Growth Q	-16.53x
Revenue Growth Years	0x
Revenue Growth3 Y	2.53x
Revenue Growth5 Y	5.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.42
Assets	$53.4M
Cash	$29.6M
Current Assets	$44.1M
Current Liabilities	$23.8M
Debt	$18.9M
Debt EBITDA	$22.21
Debt Equity	$0.64
Equity	$29.6M
Liabilities	$23.8M
Long Term Assets	$9.2M
Long Term Liabilities	$0
Net Cash	$10.7M
Net Cash By Market Cap	$66.48
Net Cash Growth	-14.82%
Net Debt EBITDA	$-12.59
Net Debt Equity	$-0.36
Tangible Book Value	$28.5M
Tangible Book Value Per Share	$3.65
WACC	20.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.86
Inventory Turnover	2.05
Net Working Capital	$9.6M
Quick ratio	1.53
Working Capital	$20.3M
Working Capital Turnover	$0.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-85.28%
200-day SMA	3.48
3Y total return	-80.84%
50-day SMA	2.27
50-day SMA vs 200-day SMA	50under200
All Time High	509.9
All Time High Change	-99.6%
All Time High Date	2023-12-18
All Time Low	1.64
All Time Low Change	25.53%
All Time Low Date	2026-04-02
ATR	0.23
Beta	7.34
Beta1y	0.88
Beta2y	0.78
Ch YTD	-53.18
High	2.25
High52	17.18
High52 Date	2025-08-25
High52ch	-88.01%
Low	1.92
Low52	1.64
Low52 Date	2026-04-02
Low52ch	25.53%
Ma50ch	-9.13%
Premarket Change Percent	0
Premarket Price	$2.28
Price vs 200-day SMA	-40.87%
RSI	47.73
RSI Monthly	43.52
RSI Weekly	34.57
Sharpe ratio	-1.36x
Sortino ratio	-1.79
Total Return	-0.05%
Tr YTD	-53.18
Tr1m	-15.92%
Tr1w	8.42%
Tr3m	-4.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$608,182
Operating Income Growth	-83.29
Operating Income Growth Q	-3.05
Operating Income Growth3 Y	-34.16
Operating Income Growth5 Y	-23.72
Operating margin	2.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,941,223%
Float Percent	24.8%
Net Borrowing	7,456,982
Shares Institutions	0.13%
Shares Out	7,827,355
Shares Qo Q	0%
Shares Yo Y	0.05%
Short Float	0.83%
Short Ratio	0.89
Short Shares	0.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-3.7M
Average Volume	17,301.7x
Bv Per Share	3.79
CAPEX	$-6.6M
Ch1m	-15.92
Ch1w	8.42
Ch1y	-85.28
Ch3m	-4.41
Ch3y	-80.84
Ch6m	-23.13
Change	-9.65%
Change From Open	-8.44
Close	2.28
Days Gap	-1.32
Depreciation Amortization	243,403
Dollar Volume	22,105.9
Earnings Date	2026-08-19
Earnings Time	amc
EBIT	$608,182
EBITDA	$851,585
EPS	$0.15
F Score	4
FCF	$-3.7M
FCF EV Yield	-68.95x
FCF Per Share	$-0.48
Financing CF	7,353,245
Fiscal Year End	September
Founded	2,006
Graham Number	3.60093
Graham Upside	74.8
Income Tax	$214,572
Investing CF	-10,791,736
Ipr	-74.25
Iprfo	-74.25
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-08-20
Last Report Date	2025-09-30
Last Split Date	2026-03-16
Last Split Type	Reverse
Last10k Filing Date	2026-02-10
Lynch Fair Value	$0.76
Lynch Upside	-63.06
Ma150	2.67
Ma150ch	-22.93%
Ma20	2.01
Ma20ch	2.74%
Net CF	-674,549
Next Earnings Date	2026-08-19
Open	2.25
Optionable	No
P OCF Ratio	5.55
Position In Range	42.42
Post Close	2.06
Postmarket Change Percent	-3.4
Postmarket Price	$1.99
Ppne	7,980,542
Pre Close	2.28
Price Date	2026-07-24
Price EBITDA	$18.93
Ptbv Ratio	0.57
Relative Volume	0.62x
Revenue	20,687,274x
Tax By Revenue	1.04x
Tax Rate	13.45%
Tr6m	-23.13%
Volume	10,731
Z Score	5.27

Jin Medical International Ltd. (ZJYL)

Coverage state: Market snapshot only — no published research

Generate the first ZJYL analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ZJYL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZJYL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ZJYL

Frequently asked questions